Rare Earths Americas, Inc. financials

REA CIK 0002095743

Source: EDGAR filings · Built 2026-08-12T00:28:04Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Free Cash Flow -10.68M -4.58M 254.00K 112.00K
EBITDA -12.74M -4.78M -541.00K -299.00K
Working Capital 75.56M 17.70M 19.25M
Net Debt -10.04M -20.34M -22.82M
Return on Equity (ROE) -15.05% -175.96% 52.63% 55.33%
Return on Assets (ROA) -12.49% -35.37%
Current Ratio 31.80× 6.70× 5.99×
Debt-to-Equity 0.00× 0.00× 0.00×
Effective Tax Rate 0.00% 0.00% 0.00%
Cash Conversion Ratio 0.80× 0.26× -0.43× -0.37×
Accruals Ratio -0.02× -0.26×
CapEx Coverage -24.79× -28.19× 128.00×
Free Cash Flow Per Share $-0.59 $-0.31 $0.03 $0.01

Income Statement

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Operating Expenses 12.78M 4.80M 543.00K 300.00K
Operating Income (Loss) -12.78M -4.80M -543.00K -300.00K
Income Tax Expense (Benefit) 0 0 0
Net Income (Loss) Attributable to Parent -12.79M -16.78M -601.00K -301.00K
Earnings Per Share, Basic $-0.70 $-1.12 $-0.06 $-0.03
Weighted Average Number of Shares Outstanding, Basic 18.19M 14.97M 9.38M 9.38M
Earnings Per Share, Diluted $-0.70 $-1.12 $-0.06 $-0.03
Weighted Average Number of Shares Outstanding, Diluted 18.19M 14.97M 9.38M 9.38M

Balance Sheet

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Cash and Cash Equivalents, at Carrying Value 10.10M 20.36M 22.84M
Assets, Current 78.01M 20.80M 23.11M
Assets 102.38M 47.44M 48.84M
Liabilities, Current 2.45M 3.10M 3.86M
Liabilities 15.10M 35.63M 20.37M
Stockholders' Equity Attributable to Parent 85.01M 9.54M 26.19M
Common Stock, Shares, Outstanding 19.95M 14.97M 14.97M

Cash Flow Statement

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Net Cash Provided by (Used in) Operating Activities -10.27M -4.43M 256.00K 112.00K
Payments to Acquire Property, Plant, and Equipment 414.00K 157.00K 2.00K 0
Net Cash Provided by (Used in) Investing Activities -67.15M -209.00K -2.00K 0
Net Cash Provided by (Used in) Financing Activities 64.76M 2.23M -206.00K -100.00K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (REA CIK 0002095743), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

YMT

Yimutian Inc.

FAF

FIRST AMERICAN FINANCIAL CORPORATION

ODYY

Odyssey Health, Inc.